KPIs & Operating Metrics(New)
Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent LeasesGoodwillGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityLong-Term InvestmentsMinority InterestNon-Current AssetsNon-Current DebtNon-Current Deferred Tax LiabilityNon-Current Deferred Tax LiabilityNotes PayablesOperating LeasesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)Property, Plant & Equipment (Net)ReceivablesReceivables - NetReceivables - OtherRetained EarningsShareholder's EquityShares OutstandingShort term DebtShort-term InvestmentsTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury SharesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Cvs Health (CVS) Total Debt (2016 - 2025)

Cvs Health's Total Debt history spans 17 years, with the latest figure at $64.6 billion for Q4 2025.

  • For the quarter ending Q4 2025, Total Debt rose 3.07% year-over-year to $64.6 billion, compared with a TTM value of $64.6 billion through Dec 2025, up 3.07%, and an annual FY2025 reading of $64.6 billion, up 3.07% over the prior year.
  • Total Debt for Q4 2025 was $64.6 billion at Cvs Health, up from $61.8 billion in the prior quarter.
  • The five-year high for Total Debt was $66.4 billion in Q2 2024, with the low at $50.5 billion in Q4 2022.
  • Average Total Debt over 5 years is $59.6 billion, with a median of $60.4 billion recorded in 2024.
  • Year-over-year, Total Debt fell 17.19% in 2021 and then grew 18.58% in 2023.
  • Tracing CVS's Total Debt over 5 years: stood at $56.2 billion in 2021, then fell by 10.15% to $50.5 billion in 2022, then increased by 16.57% to $58.8 billion in 2023, then increased by 6.47% to $62.6 billion in 2024, then grew by 3.07% to $64.6 billion in 2025.
  • Per Business Quant, the three most recent readings for CVS's Total Debt are $64.6 billion (Q4 2025), $61.8 billion (Q3 2025), and $60.3 billion (Q2 2025).